“Longevity medicine has reached an inflection point.” - CEO Eric Marcotulli in Longevity.Technology

Newsletters Dark mode

Plus: Dr. Guarente talks evidence vs. hype, Basis featured in Rolling Stone, and free Creatine+ samples in September shipments.

Elysium Newsletter <[email protected]>

to the archive

Sunday, September 27, 2026

Elysium Health announces the official opening of The Elysium Longevity Institute, a physician-led, personalized longevity program. The company is also celebrating the launch of Creatine+ by including free samples in every shipment starting mid-September. Elysium Health is featured in various media outlets, including Longevity.Technology, CBS Austin, and Rolling Stone.

Read this email as text

for screen readers, or when images don't load

Thank you for reading our September newsletter. This month’s edition is 920 words, about a 3-minute read.

Want to get the Elysium Newsletter in your inbox? Sign up here.

Volume 10, Issue 9

Elysium has entered its biggest chapter yet. We officially opened The Elysium Longevity Institute (TELI)—our physician-led, personalized longevity program is now available to eligible users. We're also still buzzing from the launch of Creatine+, and to celebrate we’re sending free samples in every shipment starting mid-September. In the media, Longevity.Technology took a closer look at TELI, Creatine+ earned a spotlight from CBS Austin, Rolling Stone picked Basis in its NAD+ supplement roundup, AIR MAIL spotlighted Mosaic for inside out skin protection, and Dr. Leonard Guarente was interviewed on the Adding Years podcast to separate science from hype. Plus, see why Robb Report turned to Elysium for the real story on Klotho, longevity's buzziest protein.

The Elysium Longevity Institute is officially open

THE ELYSIUM LONGEVITY INSTITUTE

Email headers

sender, ESP fingerprints, unsubscribe and auth headers

As received, minus the delivery side: the archive's own addresses appear as [recipient], relay hops and signatures are left out, and unsubscribe links are trimmed to their host.

Received-SPF: pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 149.72.85.18 as permitted sender) receiver=[receiver]; client-ip=149.72.85.18; envelope-from="[recipient]@send.elysiumhealth.com"; helo=o1409.shared.klaviyomail.com;
Authentication-Results: [receiver]; dkim=pass header.d=elysiumhealth.com header.s=kl2 header.b=uU24kwsD; dmarc=pass header.from=elysiumhealth.com policy.dmarc=quarantine; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=o1409.shared.klaviyomail.com; spf=pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 149.72.85.18 as permitted sender) smtp.mailfrom=[recipient]@send.elysiumhealth.com; arc=none smtp.remote-ip=149.72.85.18
Content-Type: multipart/alternative; boundary=b7d7ce1601e7b3145bbe55a0012562593eb35695a8be7a98e0b05142e1c2
Date: Sun, 27 Sep 2026 12:15:34 +0000 (UTC)
From: Elysium Newsletter <[email protected]>
Mime-Version: 1.0
Message-ID: <g_59u8dcRH-Xue2Oxznjog@geopod-ismtpd-35>
Subject: “Longevity medicine has reached an inflection point.” - CEO Eric Marcotulli in Longevity.Technology
Reply-To: [email protected]
List-Unsubscribe: <https://manage.kmail-lists.com/…>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Kmail-Account: R8xQKv
X-Kmail-Message: 01M3D1CZNRWF7G1SBBRSN6FAV3
X-Kmail-Ops: 01KX28G5HSKQA9CNV085MJW4AC
X-Report-Abuse: Please report any spam or abuse to: [email protected]
X-SG-EID: u001.Xv32TvI6iuV+tZ4vlqHO3FesVXhKuLs/35vTDiHBGEoe78YqTYKTrjCY1Ecr8LbUFtuxQpd9gm/JrHgphOlryD37dAClzeCsbSc1ZkqyfDvg5RPuke+mQR0OhsRpJnE7rRyWaDOEyo23sTuTy+0ryP/mHu3IVVm9gI8E0QC29H9D0OF7aysijIivQIvkxhqn9p2yjPFBE2/AntHgxQe5zCnTj4sqCdbd9r0dnj68nlV9WMKl3+XVfjnetOnYVT0P
X-SG-ID: u001.SdBcvi+Evd/bQef8eZF3BiU3Zi1S53GtqGa3TWBmqe75yn5aYrkvkfG+ZGKrHRvqHEqNnYhXzKEMbIPUuNbUdfpjphyJI24ahdp5cMyD+gtd10HMsYQGG+9KCgoFZ++5Q7yRhM+djsaRvx1euBg3rco4YLZx9lDfqNZQJfRXNxrPbw7tcQpapaucE5r0VlzeAKTcyKp365BaAV4zNWNNeaNQiHlgsrvwEFbjh9QU0Q21RtEgMfQUotvHhVOjOksrWop5UgtWgTO1vuEaKhzcZ1ZYrVTrk42992phzYCOJGPjBJQF8Yq32rxBOHWranmd9AOfCItGw9LhILR5FYcTTu+WT7VDcryqYgyGQf5wEWHApS/0Z3z7/G73xx7MnLoa
X-Entity-ID: u001.lP8bpbcNOc7n5/pI/ei+9g==

Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.